marine drugs Article Effects of Chitosan–Gentamicin Conjugate Supplement on Non-Specific Immunity, Aquaculture Water, Intestinal Histology and Microbiota of Pacific White Shrimp (Litopenaeus vannamei) Fengyan Liang 1,2, Chengpeng Li 1,*, Tingting Hou 1, Chongqing Wen 2, Songzhi Kong 1, Dong Ma 3, Chengbo Sun 2,4,* and Sidong Li 1 1 School of Chemistry and Environmental Science, Guangdong Ocean University, Zhanjiang 524088, China;
[email protected] (F.L.);
[email protected] (T.H.);
[email protected] (S.K.);
[email protected] (S.L.) 2 Department of Fisheries, Guangdong Ocean University, Zhanjiang 524088, China;
[email protected] 3 Department of Biomedical Engineering, Jinan University, Guangzhou 510632, China;
[email protected] 4 Southern Marine Science and Engineering Guangdong Laboratory, Zhanjiang 524025, China * Correspondence:
[email protected] (C.L.);
[email protected] (C.S.) Received: 8 July 2020; Accepted: 7 August 2020; Published: 10 August 2020 Abstract: When the aquaculture water environment deteriorates or the temperature rises, shrimp are susceptible to viral or bacterial infections, causing a large number of deaths. This study comprehensively evaluated the effects of the oral administration of a chitosan–gentamicin conjugate (CS-GT) after Litopenaeus vannamei were infected with Vibrio parahaemolyticus, through nonspecific immunity parameter detection, intestinal morphology observation, and the assessment of microbial flora diversification by 16S rRNA gene sequencing. The results showed that the oral administration of CS-GT significantly increased total hemocyte counts and reduced hemocyte apoptosis in shrimp (p < 0.05). The parameters (including superoxide dismutase, glutathione peroxidase, glutathione, lysozyme, acid phosphatase, alkaline phosphatase, and phenoloxidase) were significantly increased (p < 0.05).